Literature DB >> 16810676

Deep brain stimulation: neuropsychological and neuropsychiatric issues.

Valerie Voon1, Cynthia Kubu, Paul Krack, Jean-Luc Houeto, Alexander I Tröster.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor, cognitive, neuropsychiatric, autonomic, and other nonmotor symptoms. The efficacy of deep brain stimulation (DBS) for the motor symptoms of advanced PD is well established. However, the effects of DBS on the cognitive and neuropsychiatric symptoms are less clear. The neuropsychiatric aspects of DBS for PD have recently been of considerable clinical and pathophysiological interest. As a companion to the preoperative and postoperative sections of the DBS consensus articles, this article reviews the published literature on the cognitive and neuropsychiatric aspects of DBS for PD. The majority of the observed neuropsychiatric symptoms are transient, treatable, and potentially preventable. Outcome studies, methodological issues, pathophysiology, and preoperative and postoperative management of the cognitive and neuropsychiatric aspects and complications of DBS for PD are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16810676     DOI: 10.1002/mds.20963

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  79 in total

1.  Building a neuroscience of pleasure and well-being.

Authors:  Kent C Berridge; Morten L Kringelbach
Journal:  Psychol Well Being       Date:  2011-10-24

Review 2.  [Deep brain stimulation for Parkinson's disease].

Authors:  J Herzog; G Deuschl
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

3.  The effect of cortical repetitive transcranial magnetic stimulation on cognitive event-related potentials recorded in the subthalamic nucleus.

Authors:  M Baláz; H Srovnalová; I Rektorová; I Rektor
Journal:  Exp Brain Res       Date:  2010-04-09       Impact factor: 1.972

4.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

5.  A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation.

Authors:  Angelo Antonini; Ioannis U Isaias; Giorgia Rodolfi; Andrea Landi; Francesca Natuzzi; Chiara Siri; Gianni Pezzoli
Journal:  J Neurol       Date:  2010-10-23       Impact factor: 4.849

6.  Neural correlates of STN DBS-induced cognitive variability in Parkinson disease.

Authors:  M C Campbell; M Karimi; P M Weaver; J Wu; D C Perantie; N A Golchin; S D Tabbal; J S Perlmutter; T Hershey
Journal:  Neuropsychologia       Date:  2008-07-19       Impact factor: 3.139

7.  Frequency dependence of behavioral modulation by hippocampal electrical stimulation.

Authors:  Giorgio La Corte; Yina Wei; Nick Chernyy; Bruce J Gluckman; Steven J Schiff
Journal:  J Neurophysiol       Date:  2013-11-06       Impact factor: 2.714

Review 8.  The role of the subthalamic nucleus in cognition.

Authors:  David B Weintraub; Kareem A Zaghloul
Journal:  Rev Neurosci       Date:  2013       Impact factor: 4.353

9.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

10.  Cognitive declines after unilateral deep brain stimulation surgery in Parkinson's disease: a controlled study using Reliable Change, part II.

Authors:  Ania Mikos; Laura Zahodne; Michael S Okun; Kelly Foote; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2009-11-26       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.